Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Pharmaceuticals & Biotech
Create a narrative
Shield Therapeutics Community
AIM:STX Community
0
Narratives
written by author
0
Comments
on narratives written by author
10
Fair Values set
on narratives written by author
Create a narrative
Shield Therapeutics
Latest
Undervalued
Overvalued
Community Investing Ideas
There are no community narratives available.
Your Valuation for
STX
STX
Shield Therapeutics
Your Fair Value
UK£
Current Price
UK£0.026
53.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-50m
113m
2015
2018
2021
2024
2025
2027
2030
Revenue US$113.3m
Earnings US$16.4m
Advanced
Set Fair Value